Abstract
Advances in 3D bioprinting technology are increasingly shaping medical applications, offering practical opportunities in tissue engineering, regenerative medicine, and personalized healthcare. By enabling the precise deposition of cells and biomaterials, 3D bioprinting allows the fabrication of functional, tissue-like constructs that reproduce key aspects of native human organs. Concrete progress has been demonstrated in applications, such as cartilage repair, skin grafts, and liver tissue models, which illustrate the translational potential of this technology. In addition, 3D bioprinted constructs are being explored for organ transplantation, drug testing, and disease modeling, where they can provide more physiologically relevant data than traditional models. Despite these advances, major challenges remain, including vascularization, mechanical stability, and ensuring long-term tissue functionality. The development of robust bioinks, regulatory acceptance, and the high cost of bioprinting platforms also represent significant barriers to widespread clinical adoption. This article reviews both the opportunities and challenges of 3D bioprinting in medicine, highlighting recent technological progress, ongoing preclinical research, and potential strategies for overcoming current limitations to accelerate clinical translation. Ultimately, 3D bioprinting is moving from proof-of-concept studies toward early clinical applications, underscoring its potential to become a transformative tool in regenerative medicine.